E

Exact Sciences

Finding Cancer Early When It's More Treatable

Madison, WI
6,000+

About Exact Sciences

Industry: Cancer Diagnostics
Founded: 1995
Founders: Stanley Lapidus, Anthony Shuber
Status: Public (NASDAQ: EXAS)

Funding & Growth

Total Raised: $3B+
Valuation: $10B+ market cap
Stage: Public
Key Investors:
Public markets

✓ Pros

  • • Market leader in Cologuard
  • • Strong revenue and growth
  • • Mission-driven culture
  • • Multi-cancer early detection pipeline
  • • Good work-life balance

✗ Cons

  • • Madison, WI location (not major hub)
  • • Large company processes
  • • Competition from liquid biopsy
  • • Sales-driven organization

Get weekly job alerts